A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis
Sponsored by Teva Branded Pharmaceutical Products R&D, Inc.
About this trial
Last updated 15 years ago
Study ID
PM025
Status
Completed
Type
Observational
Placebo
No
Accepting
20 to 57 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 16 years ago
What is this trial about?
It is thought that treating Multiple Sclerosis with Novantrone for a short period of time
prior to treatment with Copaxone may enhance the onset effect of Copaxone.
What are the participation requirements?
Inclusion Criteria
- Participation & completion of the NC-100 Clinical Trial. - Able and willing to sign an Informed Consent.
Exclusion Criteria
none